EcoDrugPlus

B2 Bradykinin Receptor-Like

Ensembl ID : ENSPREG00000004997
Gene Symbol: LOC103459963
3 Cross references
147 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPREG00000004267
Gene Symbol: BCL2
3 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPREG00000022250
Gene Symbol: BCL2L1
4 Cross references
216 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSPREG00000005390
Gene Symbol: BCL2L10
3 Cross references
128 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPREG00000007458
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:

Bdnf/nt-3 Growth Factors Receptor-Like

Ensembl ID : ENSPREG00000002914
Gene Symbol: LOC103473467
3 Cross references
207 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPREG00000012701
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:

C-C Chemokine Receptor Type 9-Like

Ensembl ID : ENSPREG00000009058
Gene Symbol: LOC103460846
3 Cross references
188 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSPREG00000002599
Gene Symbol: CCR9
3 Cross references
193 Possible Orthologues:

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSPREG00000019127
Gene Symbol: CXCR2
3 Cross references
275 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSPREG00000019392
Gene Symbol: LOC103478632
2 Cross references
389 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSPREG00000019447
Gene Symbol: LOC103478713
2 Cross references
377 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).